NasdaqGM:EXAIBiotechs
AI Drug Discovery Stocks Retail Investors Are Watching After Claude Science
Anthropic’s launch of Claude Science has thrown fresh attention on stocks that sit at the intersection of artificial intelligence and drug discovery, where software meets lab science. For investors watching this theme, the question is which companies might gain most from large pharma and biotech groups exploring AI tools for protein modelling, target identification and faster experiments, and which might struggle if regulation tightens. This article picks out 3 stocks from our AI Powered Drug...